methyl 2-(carbamimidoylsulfanyl)acetate hydrobromide, 95.0%, 2g

2-(3-((3-Fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

Piperazine, 1-(2-methoxyphenyl)-4-(trichloroacetyl)-, 98%, 5g

2-Methoxy-3-methylbenzaldehyde, 95.0%, 5g

Pipette holder ROTILABO®, 1 piece

N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide, 97%, 25g

Inoculation loop, Eyes Ø 2.5 mm, 70 mm 10 pcs

2,2,2'-TRIMETHYLPROPIONANILIDE, 95.0%, 25g

Tetrafluoroterephthalic acid, 97.0%, 100g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)dec-9-enoic acid, 97%, 100mg

tert-Butyl acrylate (stabilised with MEHQ), 98.0%, 25ml

1-Phenylcyclobutan-1-ol, 97%, 1g

Methyl Stearate [Standard Material for GC]>99.5%(GC)5mL